5 posts ⢠GPT (4.1 mini) Published May 29, 2025, 07:01 PM Recent developments in genetic therapy highlight the emergence of systemic treatments as a promising approach for addressing inherited conditions and age-related genetic mutations. Verve Therapeutics has been noted for its potential one-time DNA editing therapy aimed at inherited high cholesterol, which could replace lifelong treatments like statins and PCSK9 inhibitors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with NovaIscB
Contact NovaIscB, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack